Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
· manilatimes.net
- PDUFA target date of December 22, 2026 for lorundrostat; commercial preparations on-track for launch upon approval -
- PDUFA target date of December 22, 2026 for lorundrostat; commercial preparations on-track for launch upon approval -
- Appoints accomplished cardiovascular m...